Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2023418281', 'doi': 'https://doi.org/10.1016/0006-3223(86)90125-3', 'title': 'The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome', 'display_name': 'The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome', 'publication_year': 1986, 'publication_date': '1986-06-01', 'ids': {'openalex': 'https://openalex.org/W2023418281', 'doi': 'https://doi.org/10.1016/0006-3223(86)90125-3', 'mag': '2023418281', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/3011130'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/0006-3223(86)90125-3', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S205482884', 'display_name': 'Biological Psychiatry', 'issn_l': '0006-3223', 'issn': ['0006-3223', '1873-2402'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5060955934', 'display_name': 'Bryon Adinoff', 'orcid': 'https://orcid.org/0000-0002-7464-2642'}, 'institutions': [{'id': 'https://openalex.org/I4210121815', 'display_name': 'National Institute on Alcohol Abuse and Alcoholism', 'ror': 'https://ror.org/02jzrsm59', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210121815']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Bryon Adinoff', 'raw_affiliation_strings': ['From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA'], 'affiliations': [{'raw_affiliation_string': 'From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA', 'institution_ids': ['https://openalex.org/I4210121815']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019364591', 'display_name': 'Edward Majchrowicz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121815', 'display_name': 'National Institute on Alcohol Abuse and Alcoholism', 'ror': 'https://ror.org/02jzrsm59', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210121815']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Edward Majchrowicz', 'raw_affiliation_strings': ['From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA'], 'affiliations': [{'raw_affiliation_string': 'From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA', 'institution_ids': ['https://openalex.org/I4210121815']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073077661', 'display_name': 'Peter Martin', 'orcid': 'https://orcid.org/0000-0002-9781-4961'}, 'institutions': [{'id': 'https://openalex.org/I4210121815', 'display_name': 'National Institute on Alcohol Abuse and Alcoholism', 'ror': 'https://ror.org/02jzrsm59', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210121815']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Peter R. Martin', 'raw_affiliation_strings': ['From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA'], 'affiliations': [{'raw_affiliation_string': 'From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA', 'institution_ids': ['https://openalex.org/I4210121815']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5032882659', 'display_name': 'Markku Linnoila', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210121815', 'display_name': 'National Institute on Alcohol Abuse and Alcoholism', 'ror': 'https://ror.org/02jzrsm59', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210121815']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Markku Linnoila', 'raw_affiliation_strings': ['From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA'], 'affiliations': [{'raw_affiliation_string': 'From the Laboratory of Clinical and Pre-Clinical Studies, DICBR, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MDUSA', 'institution_ids': ['https://openalex.org/I4210121815']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5060955934'], 'corresponding_institution_ids': ['https://openalex.org/I4210121815'], 'apc_list': {'value': 4990, 'currency': 'USD', 'value_usd': 4990, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.719, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 23, 'citation_normalized_percentile': {'value': 0.774032, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '21', 'issue': '7', 'first_page': '643', 'last_page': '649'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12494', 'display_name': 'Diagnosis and Management of Wernicke-Korsakoff Syndrome', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12494', 'display_name': 'Diagnosis and Management of Wernicke-Korsakoff Syndrome', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10077', 'display_name': 'Molecular Mechanisms of Synaptic Plasticity and Neurological Disorders', 'score': 0.9839, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11633', 'display_name': 'Effects of Prenatal Alcohol Exposure on Offspring', 'score': 0.9832, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/inverse-agonist', 'display_name': 'Inverse agonist', 'score': 0.8465144}, {'id': 'https://openalex.org/keywords/withdrawal-syndrome', 'display_name': 'Withdrawal syndrome', 'score': 0.7440471}, {'id': 'https://openalex.org/keywords/flumazenil', 'display_name': 'Flumazenil', 'score': 0.5698157}, {'id': 'https://openalex.org/keywords/alcohol-withdrawal', 'display_name': 'Alcohol Withdrawal', 'score': 0.520168}, {'id': 'https://openalex.org/keywords/benzodiazepine-therapy', 'display_name': 'Benzodiazepine Therapy', 'score': 0.517276}], 'concepts': [{'id': 'https://openalex.org/C2776175493', 'wikidata': 'https://www.wikidata.org/wiki/Q210402', 'display_name': 'Diazepam', 'level': 2, 'score': 0.8529246}, {'id': 'https://openalex.org/C89951826', 'wikidata': 'https://www.wikidata.org/wiki/Q1671731', 'display_name': 'Inverse agonist', 'level': 4, 'score': 0.8465144}, {'id': 'https://openalex.org/C2778173252', 'wikidata': 'https://www.wikidata.org/wiki/Q83871', 'display_name': 'Benzodiazepine', 'level': 3, 'score': 0.77175}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.75266325}, {'id': 'https://openalex.org/C2776922375', 'wikidata': 'https://www.wikidata.org/wiki/Q498902', 'display_name': 'Withdrawal syndrome', 'level': 2, 'score': 0.7440471}, {'id': 'https://openalex.org/C2780161600', 'wikidata': 'https://www.wikidata.org/wiki/Q153', 'display_name': 'Ethanol', 'level': 2, 'score': 0.711455}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.5752676}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5712178}, {'id': 'https://openalex.org/C2778409475', 'wikidata': 'https://www.wikidata.org/wiki/Q421920', 'display_name': 'Flumazenil', 'level': 4, 'score': 0.5698157}, {'id': 'https://openalex.org/C16613235', 'wikidata': 'https://www.wikidata.org/wiki/Q285982', 'display_name': 'Endogeny', 'level': 2, 'score': 0.45523834}, {'id': 'https://openalex.org/C168258287', 'wikidata': 'https://www.wikidata.org/wiki/Q60147', 'display_name': 'GABAA receptor', 'level': 3, 'score': 0.4546507}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.44032332}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.37603468}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.36308345}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.32393104}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.29930076}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.11314133}], 'mesh': [{'descriptor_ui': 'D001570', 'descriptor_name': 'Benzodiazepinones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000431', 'descriptor_name': 'Ethanol', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D011963', 'descriptor_name': 'Receptors, GABA-A', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D013375', 'descriptor_name': 'Substance Withdrawal Syndrome', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001143', 'descriptor_name': 'Arousal', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001143', 'descriptor_name': 'Arousal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001570', 'descriptor_name': 'Benzodiazepinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001921', 'descriptor_name': 'Brain', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001921', 'descriptor_name': 'Brain', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003975', 'descriptor_name': 'Diazepam', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D003975', 'descriptor_name': 'Diazepam', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000431', 'descriptor_name': 'Ethanol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005442', 'descriptor_name': 'Flumazenil', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009048', 'descriptor_name': 'Motor Skills', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D009048', 'descriptor_name': 'Motor Skills', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011919', 'descriptor_name': 'Rats, Inbred Strains', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011963', 'descriptor_name': 'Receptors, GABA-A', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013375', 'descriptor_name': 'Substance Withdrawal Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/0006-3223(86)90125-3', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S205482884', 'display_name': 'Biological Psychiatry', 'issn_l': '0006-3223', 'issn': ['0006-3223', '1873-2402'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/3011130', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.78, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 36, 'referenced_works': ['https://openalex.org/W1605353467', 'https://openalex.org/W1940656453', 'https://openalex.org/W1968936535', 'https://openalex.org/W1970666380', 'https://openalex.org/W1974780959', 'https://openalex.org/W1978013837', 'https://openalex.org/W1981209032', 'https://openalex.org/W1982411339', 'https://openalex.org/W1983404085', 'https://openalex.org/W1989245429', 'https://openalex.org/W1989334851', 'https://openalex.org/W1991861023', 'https://openalex.org/W1995136974', 'https://openalex.org/W1995915134', 'https://openalex.org/W1999113647', 'https://openalex.org/W2001583156', 'https://openalex.org/W2006684969', 'https://openalex.org/W2016003610', 'https://openalex.org/W2019298697', 'https://openalex.org/W2027127607', 'https://openalex.org/W2028633116', 'https://openalex.org/W2032302905', 'https://openalex.org/W2076283948', 'https://openalex.org/W2076501023', 'https://openalex.org/W2082833382', 'https://openalex.org/W2088050052', 'https://openalex.org/W2098069932', 'https://openalex.org/W2112280467', 'https://openalex.org/W2226881053', 'https://openalex.org/W2399045151', 'https://openalex.org/W2414774559', 'https://openalex.org/W2414810613', 'https://openalex.org/W2795740701', 'https://openalex.org/W4253964648', 'https://openalex.org/W4324289996', 'https://openalex.org/W45773947'], 'related_works': ['https://openalex.org/W4231335442', 'https://openalex.org/W2412904185', 'https://openalex.org/W2137598989', 'https://openalex.org/W2086201446', 'https://openalex.org/W2067900232', 'https://openalex.org/W2047587919', 'https://openalex.org/W2019845133', 'https://openalex.org/W1996335319', 'https://openalex.org/W1985381435', 'https://openalex.org/W1970666380'], 'abstract_inverted_index': {'It': [0], 'has': [1], 'been': [2], 'suggested': [3], 'that': [4, 25, 89], 'the': [5, 10, 18, 28, 35, 43, 69, 72, 78, 91, 104, 113, 116, 128], 'signs': [6], 'and': [7, 49, 109], 'symptoms': [8], 'of': [9, 21, 58, 71, 81, 85, 115], 'ethanol': [11, 62, 73, 92, 117], 'withdrawal': [12, 74, 93, 118], 'syndrome': [13, 94], 'may': [14], 'be': [15], 'due': [16], 'to': [17, 27, 56], 'increased': [19], 'production': [20], 'an': [22, 99], '“inverse': [23], 'agonist”': [24], 'binds': [26], 'central': [29, 44, 105, 129], 'benzodiazepine': [30], '(BZ)': [31], 'recognition': [32, 46, 107, 131], 'site': [33], 'in': [34, 122], 'brain.': [36], 'Ro': [37, 50, 64], '15-1788': [38, 51, 65], '(a': [39], 'potent': [40], 'antagonist': [41], 'at': [42, 120, 127], 'BZ': [45, 106, 130], 'site),': [47], 'diazepam,': [48], 'plus': [52], 'diazepam': [53, 111], 'were': [54], 'administered': [55], 'groups': [57], 'rats': [59], 'undergoing': [60], 'overt': [61], 'withdrawal.': [63], 'did': [66], 'not': [67, 96], 'alter': [68], 'severity': [70, 114], 'reactions,': [75], 'but': [76], 'antagonized': [77], 'ameliorative': [79], 'effect': [80], 'diazepam.': [82], 'The': [83], 'results': [84], 'our': [86], 'studies': [87], 'suggest': [88], '1.(1)': [90], 'is': [95], 'produced': [97], 'by': [98, 124], 'endogenous': [100], 'ligand': [101], 'acting': [102], 'on': [103], 'site,': [108], '2.(2)': [110], 'decreases': [112], 'syndrome,': [119], 'least': [121], 'part,': [123], 'its': [125], 'action': [126], 'site.': [132]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2023418281', 'counts_by_year': [], 'updated_date': '2024-08-13T08:01:08.963951', 'created_date': '2016-06-24'}